BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

869 related articles for article (PubMed ID: 18517157)

  • 1. Environmental chemicals in people: challenges in interpreting biomonitoring information.
    LaKind JS; Barraj L; Tran N; Aylward LL
    J Environ Health; 2008 May; 70(9):61-4. PubMed ID: 18517157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The U.S. National Health and Nutrition Examination Survey and human exposure to environmental chemicals.
    Calafat AM
    Int J Hyg Environ Health; 2012 Feb; 215(2):99-101. PubMed ID: 21937270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.
    Hays SM; Becker RA; Leung HW; Aylward LL; Pyatt DW
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):96-109. PubMed ID: 17030369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human exposure assessment to environmental chemicals using biomonitoring.
    Calafat AM; Ye X; Silva MJ; Kuklenyik Z; Needham LL
    Int J Androl; 2006 Feb; 29(1):166-71; discussion 181-5. PubMed ID: 16466536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uses and issues of biomonitoring.
    Needham LL; Calafat AM; Barr DB
    Int J Hyg Environ Health; 2007 May; 210(3-4):229-38. PubMed ID: 17157561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. German Environmental Survey (GerES): human biomonitoring as a tool to identify exposure pathways.
    Becker K; Conrad A; Kirsch N; Kolossa-Gehring M; Schulz C; Seiwert M; Seifert B
    Int J Hyg Environ Health; 2007 May; 210(3-4):267-9. PubMed ID: 17317311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporting results of human biomonitoring of environmental chemicals to study participants: a comparison of approaches followed in two Canadian studies.
    Haines DA; Arbuckle TE; Lye E; Legrand M; Fisher M; Langlois R; Fraser W
    J Epidemiol Community Health; 2011 Mar; 65(3):191-8. PubMed ID: 20628082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomonitoring: is body burden relevant to public health?
    Paustenbach D; Galbraith D
    Regul Toxicol Pharmacol; 2006 Apr; 44(3):249-61. PubMed ID: 16473444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method for generating distributions of biomonitoring equivalents to support exposure assessment and prioritization.
    Phillips MB; Sobus JR; George BJ; Isaacs K; Conolly R; Tan YM
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):434-42. PubMed ID: 24845241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions.
    Aylward LL; Kirman CR; Blount BC; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):33-44. PubMed ID: 20685286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of national human biomonitoring programme in Slovenia.
    Perharic L; Vracko P
    Int J Hyg Environ Health; 2012 Feb; 215(2):180-4. PubMed ID: 22154459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highlights of recent studies and future plans for the French human biomonitoring (HBM) programme.
    Fréry N; Vandentorren S; Etchevers A; Fillol C
    Int J Hyg Environ Health; 2012 Feb; 215(2):127-32. PubMed ID: 21940210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human biomonitoring assessment values: approaches and data requirements.
    Angerer J; Aylward LL; Hays SM; Heinzow B; Wilhelm M
    Int J Hyg Environ Health; 2011 Sep; 214(5):348-60. PubMed ID: 21764371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative interpretation of human biomonitoring data.
    Clewell HJ; Tan YM; Campbell JL; Andersen ME
    Toxicol Appl Pharmacol; 2008 Aug; 231(1):122-33. PubMed ID: 18589468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting human biomonitoring data in a public health risk context using Biomonitoring Equivalents.
    Hays SM; Aylward LL
    Int J Hyg Environ Health; 2012 Feb; 215(2):145-8. PubMed ID: 22192580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpreting NHANES biomonitoring data, cadmium.
    Ruiz P; Mumtaz M; Osterloh J; Fisher J; Fowler BA
    Toxicol Lett; 2010 Sep; 198(1):44-8. PubMed ID: 20447450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External quality assessment of human biomonitoring in the range of environmental exposure levels.
    Göen T; Schaller KH; Drexler H
    Int J Hyg Environ Health; 2012 Feb; 215(2):229-32. PubMed ID: 21937272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concept of the Flemish human biomonitoring programme.
    Schoeters G; Den Hond E; Colles A; Loots I; Morrens B; Keune H; Bruckers L; Nawrot T; Sioen I; De Coster S; Van Larebeke N; Nelen V; Van de Mieroop E; Vrijens J; Croes K; Goeyens K; Baeyens W
    Int J Hyg Environ Health; 2012 Feb; 215(2):102-8. PubMed ID: 22178406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human biomonitoring of environmental chemicals--early results of the 2007-2009 Canadian Health Measures Survey for males and females.
    Haines DA; Murray J
    Int J Hyg Environ Health; 2012 Feb; 215(2):133-7. PubMed ID: 22001329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.